Implicity Raises $23M To Broaden Use Of Its Cardiac Remote Monitoring Platform

Apr 27, 2022•over 3 years ago

Amount Raised

$23 Million

Cambridge

Description

IMPLICITY®, a leader in remote patient monitoring and cardiac data management solutions, today announced it has raised $23 million in Series A funding led by new investors: Crédit Mutuel Innovation and Bpifrance.

Company Information

Company

Implicity

Location

Cambridge, Maryland, United States

About

We believe the company has the potential to become a world-class leader in cardiac remote monitoring. The IMPLICITY® platform aggregates, normalizes and standardizes data from all implantable cardiac electronic device across all major manufacturers. This new funding comes just months after IMPLICITY received FDA clearance for a novel AI algorithm that analyzes ECG episodes from Implantable Loop Recorders (ILRs). As a digital Medtech, IMPLICITY® develops AI and knowledge based algorithms to reduce healthcare professionals' workload and allows them to potentially predict patient health status. About IMPLICITY®IMPLICITY® is a software company that provides a universal cardiac remote monitoring and research platform to clinics and service companies, helping them provide the best remote care to cardiac patients.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech